Brian Schoelkopf

Head of Investor Relations

Equibles does not estimate personal net worth.

Get an email with a short summary when Arcutis Biotherapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get ARQT alerts

About Brian Schoelkopf

Brian Schoelkopf is recorded as Head of Investor Relations at Arcutis Biotherapeutics, Inc. (ARQT). Brian Schoelkopf has spoken on 1 earnings call across 1 company, most recently for Arcutis Biotherapeutics, Inc. on August 5, 2026. Arcutis Biotherapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Arcutis Biotherapeutics, Inc. includes Todd Franklin Watanabe (CEO and Board Member), Latha Vairavan (CFO), Masaru Matsuda (General Counsel) and 7 others.

Brian Schoelkopf on recent calls

“And thank you for joining us today to review our second quarter 2026 Financial Results and Business Update. Slides for today's call are available on the Investors section of the Arcutis website.”

Head of Investor Relations, Arcutis Biotherapeutics, Inc. Q2 2026 Earnings Conference Call · August 5, 2026

Affiliation history

Arcutis Biotherapeutics, Inc. (ARQT)
Head of Investor Relations

Source not stated

Current

Company network

Arcutis Biotherapeutics, Inc.

ARQT

Current role

Biotechnology · Healthcare

Head of Investor Relations

1 appearance Latest appearance 2026-08-05

View calls and events

Leadership on record at Arcutis Biotherapeutics, Inc.

Todd Franklin Watanabe CEO, Board Member
Latha Vairavan CFO
Masaru Matsuda General Counsel
David Topper Chief Accounting Officer
Scott Burrows Chief Accounting Officer
Amit D. Munshi Board Member
Chris Peetz Board Member
Christopher Peetz Board Member
Halley E. Gilbert Board Member
Howard G. Welgus Board Member

Recent activity

Earnings call Arcutis Biotherapeutics, Inc. Q2 2026 Earnings Conference Call Arcutis Biotherapeutics, Inc. (ARQT)
2026-08-05